Graphene-based aptasensors: from molecule-interface interactions to sensor design and biomedical diagnostics

Developing Graphene-Based Nanohybrids for Electrochemical Sensing

Graphene-based nanohybrid is considered to be the most promising nanomaterial for electrochemical sensing applications due to the defects created on the graphene oxide layers. These defects provide graphene oxide unique properties, such as excellent conductivity, large specific surface area, and electrocatalytic activity. These unique properties encourage scientists to develop novel graphene-based nanohybrids and improve the sensing efficiency. This review, therefore, addresses this topic by comprehensively discussing the strategies to fabricate novel graphene based nanohybrids with high sensitivity. The combinations of graphene with various nanomaterials, such as metal nanoclusters, metal compound nanoparticles, carbon materials, polymers and peptides, in the direction of electrochemical sensing, were systematically analyzed. Meanwhile, the challenges in the functional design and application of graphene-based nanohybrids were described and the reasonable solutions were proposed.

Intracellular MicroRNA Quantification in Intact Cells: A Novel Strategy based on Reduced Graphene Oxide Based Fluorescence Quenching

Nanomaterials have been proposed as key components in biosensing, imaging, and drug-delivery since they offer distinctive advantages over conventional approaches. The unique chemical and physical properties of graphene make it possible to functionalize and develop protein transducers, therapeutic delivery vehicles, and microbial diagnostics. In this study we evaluate reduced graphene oxide (rGO) as a potential nanomaterial for quantification of microRNAs including their structural differentiation in vitro in solution and inside intact cells. Our results provide evidence for the potential use of graphene nanomaterials as a platform for developing devices that can be used for microRNA quantitation as biomarkers for clinical applications.

Reduced graphene oxide nanoribbon immobilized gold nanoparticle based electrochemical DNA biosensor for the detection of Mycobacterium tuberculosis

Tuberculosis is one of the most dreadful diseases caused by Mycobacterium tuberculosis with more than 9 million individuals suffering from it in 2014. Traditional methods of detection are not efficient enough for its quick and reliable detection; therefore, it is imperative to develop methods of its detection in the early stages. Consequently, we report a highly sensitive and selective biosensor for detection of Mycobacterium tuberculosis. In this work, gold nanoparticles (AuNPs, dia. ∼6 nm, 1.81 wt% loading) are immobilized over reduced graphene oxide nanoribbons (RGONRs). An ssDNA/Au/RGONR electrode is prepared by immobilizing Au nanoparticles followed by covalent modification of Au nanoparticles with 5'SH-ssDNA. As per the best knowledge of the authors, the target DNA of Mycobacterium tuberculosis is detected using a ssDNA/Au/RGONR bioelectrode by cyclic voltammetry and chronoamperometric methods for the first time. With high detection efficiency (0.1 fM), the ssDNA/Au/RGONR bioelectrode exhibited better signal amplification and electrochemical response as compared to bare Au and RGONR electrodes. Additionally, the ssDNA/Au/RGONR bioelectrode displayed good linear response to different concentrations of target M. tuberculosis DNA. The ssDNA/Au/RGONR has shown excellent specificity (92%) to Mycobacterium tuberculosis target DNA as compared with non-complementary DNA. The Au/RGONR matrix has the potential to be used as an immobilization platform for single-stranded probe DNAs of different diseases other than tuberculosis reported here.

Gold nanoparticles and reduced graphene oxide-amplified label-free DNA biosensor for dasatinib detection

Dasatinib or sprycel is an anticancer drug for treatment of chronic myelogenous leukemia, prostate cancer, and some of the other cancers with several adverse effects.